Search research articles
Contact Us
Filters
Showing results (51-60 of 137) with videos related to
Page
of 14
Sort By:
Journal of the National Cancer Institute
|
June 22, 2000
Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998
J K Bobo, N C Lee, S F Thames
Journal of Public Health Management and Practice : JPHMP
|
January 2, 1997
The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women
R M Henson, S W Wyatt, N C Lee
Obstetrics and Gynecology
|
March 1, 1991
Measures of sexual behavior and the risk of pelvic inflammatory disease
N C Lee, G L Rubin, D A Grimes
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries
|
August 1, 1986
Trends in the incidence of endometrial and ovarian cancers
M L Gwinn, N C Lee, G L Rubin
Journal of Clinical Epidemiology
|
January 1, 1990
Agreement of self-reported ovarian number following gynecologic surgery with medical record reports
K L Irwin, P A Wingo, N C Lee
American Journal of Obstetrics and Gynecology
|
March 1, 1990
Cigarette smoking as a risk factor for pelvic inflammatory disease
P A Marchbanks, N C Lee, H B Peterson
International Journal of Cancer
|
December 15, 1987
Reproductive history and breast cancer in a population of high fertility, Costa Rica, 1984-85
L Rosero-Bixby, M W Oberle, N C Lee
Cancer Causes & Control : CCC
|
March 3, 2001
Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States)
V B Benard, N C Lee, M Piper, et al.
Community Genetics
|
February 13, 2004
Population-based estimates of the prevalence of family history of cancer among women
I J Hall, W Burke, S Coughlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 12, 2001
Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12
H N Le, N C Lee, K Tsung, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 137) with videos related to
Sort By:
Page
of 14
Journal of the National Cancer Institute
|
June 22, 2000
Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998
J K Bobo, N C Lee, S F Thames
Journal of Public Health Management and Practice : JPHMP
|
January 2, 1997
The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women
R M Henson, S W Wyatt, N C Lee
Obstetrics and Gynecology
|
March 1, 1991
Measures of sexual behavior and the risk of pelvic inflammatory disease
N C Lee, G L Rubin, D A Grimes
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries
|
August 1, 1986
Trends in the incidence of endometrial and ovarian cancers
M L Gwinn, N C Lee, G L Rubin
Journal of Clinical Epidemiology
|
January 1, 1990
Agreement of self-reported ovarian number following gynecologic surgery with medical record reports
K L Irwin, P A Wingo, N C Lee
American Journal of Obstetrics and Gynecology
|
March 1, 1990
Cigarette smoking as a risk factor for pelvic inflammatory disease
P A Marchbanks, N C Lee, H B Peterson
International Journal of Cancer
|
December 15, 1987
Reproductive history and breast cancer in a population of high fertility, Costa Rica, 1984-85
L Rosero-Bixby, M W Oberle, N C Lee
Cancer Causes & Control : CCC
|
March 3, 2001
Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States)
V B Benard, N C Lee, M Piper, et al.
Community Genetics
|
February 13, 2004
Population-based estimates of the prevalence of family history of cancer among women
I J Hall, W Burke, S Coughlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 12, 2001
Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12
H N Le, N C Lee, K Tsung, et al.
Page
of 14